RE:RE:RE:Be AfraidAlex1726 wrote:
As i already said you never get a clear view with that very poor manager but there is one thing i would like to clarify. If i got it right, the regulator pathway would be as a natural product despite the fact that it was describe as a groundbreaking RESULT BY Dr. Li?
A groundbreaking result should incite CZO to choose a pathway that conducts to an approve drug.
A grounbreaking result could probably lead to a breakthrough designation by the FDA.
This guy is hard to follow.
Here's an introductory article;
https://www.woundsource.com/blog/how-use-fda-classifications-select-skin-and-wound-care-products
This is why you need a partner who specializes in wound healing to accelerate product development. CEAPRO has the ability to produce highly concentrated AV (economically viable). Maybe CEAPRO thinks of royalties for a finished would dressing product vs. selling an active ingredient in bulk. There's a few ways to monetize this, but we need to move to human trials first and a motivated partner could accelerate things here.